Genomic differences between retinoma and retinoblastoma

References

• Knudson AG, Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–3
   PubMed Web of Science ®Google Scholar
• Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 1999; 59: 1731s–1735s
   PubMed Web of Science ®Google Scholar
• Mairal A, Pinglier E, Gilbert E, Peter M, Validire P, Desjardins L, et al. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosome Cancer 2000; 28: 370–9
   PubMed Web of Science ®Google Scholar
• Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2001; 129: 57–63
   PubMedGoogle Scholar
• Herzog S, Lohmann DR, Buiting K, Schuler A, Horsthemke B, Rehder H, et al. Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 2001; 108: 98–104
   PubMed Web of Science ®Google Scholar
• Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, et al. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosome Cancer 2003; 36: 121–8
   PubMed Web of Science ®Google Scholar
• van der Wal JE, Hermsen MA, Gille HJ, Schouten-Van Meeteren NY, Moll AC, Imhof SM, et al. Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. J Clin Pathol 2003; 56: 26–30
   PubMed Web of Science ®Google Scholar
• Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosome Cancer 2005; 43: 294–301
   PubMed Web of Science ®Google Scholar
• Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, et al. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosome Cancer 2007; 46: 118–29
   PubMed Web of Science ®Google Scholar
• Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosome Cancer 2007; 46: 617–34
   PubMed Web of Science ®Google Scholar
• Gallie BL, Ellsworth RM, Abramson DH, Phillips RA. Retinoma: Spontaneous regression of retinoblastoma or benign manifestation of the mutation?. Br J Cancer 1982; 45: 513–21
   PubMed Web of Science ®Google Scholar
• Margo C, Hidayat A, Kopelman J, Zimmerman LE. Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol 1983; 101: 1519–31
   PubMedGoogle Scholar
• Sampieri K, Hadjistilianou T, Mari F, Speciale C, Mencarelli MA, Cetta F, et al. Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations. J Hum Genet 2006; 51: 209–16
   PubMed Web of Science ®Google Scholar
• Balmer A, Munier F, Gailloud C. Retinoma. Case studies. Ophthalmic Paediatr Genet 1991; 12: 131–7
   PubMed Web of Science ®Google Scholar
• Eagle RC, Jr, Shields JA, Donoso L, Milner RS. Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology 1989; 96: 1389–95
   PubMed Web of Science ®Google Scholar
• Rubin ML. The tale of the warped cornea: A real-life melodrama. Arch Ophthalmol 1967; 77: 711–2
   PubMedGoogle Scholar
• Brockhurst RJ, Donaldson DD. Spontaneous resolution of probable retinoblastoma. Arch Ophthalmol 1970; 84: 388–9
   PubMedGoogle Scholar
• Morris WE, LaPiana FG. Spontaneous regression of bilateral multifocal retinoblastoma with preservation of normal visual acuity. Ann Ophthalmol 1974; 6: 1192–4
   PubMedGoogle Scholar
• Reese PD. The general ophthalmological examination for the non-ophthalmologist. J Ark Med Soc 1976; 72: 387–90
   PubMedGoogle Scholar
• Singh AD, Santos CM, Shields CL, Shields JA, Eagle RC, Jr. Observations on 17 patients with retinocytoma. Arch Ophthalmol 2000; 118: 199–205
   PubMedGoogle Scholar
• Dimaras H, Coburn B, Pajovic S, Gallie BL. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog 2006; 45: 333–43
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tebar A, Dechant G, Barde YA. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 1990; 4: 487–92
   PubMed Web of Science ®Google Scholar
• Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990; 87: 5454–8
   PubMed Web of Science ®Google Scholar
• Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 1991; 65: 885–93
   PubMed Web of Science ®Google Scholar
• Hallbook F, Ibanez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991; 6: 845–58
   PubMed Web of Science ®Google Scholar
• Frade JM, Barde YA. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999; 126: 683–90
   PubMed Web of Science ®Google Scholar
• Livak K. ABI Prism 7700 Sequence Detection System, 1997.
   Google Scholar
• Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444: 61–6
   PubMed Web of Science ®Google Scholar
• Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, et al Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008.
   PubMed Web of Science ®Google Scholar
• Zografos L. Tumeurs intraoculaires. París: Société Française d'Ophtalmologie, Masson, 2002.
   Google Scholar
• Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M, et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002; 13: 215–25
   PubMedGoogle Scholar
• Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. Biochem Biophys Res Commun 2002; 291: 1138–45
   PubMed Web of Science ®Google Scholar
• Ginsberg D. E2F3-a novel repressor of the ARF/p53 pathway. Dev Cell 2004; 6: 742–3
   PubMed Web of Science ®Google Scholar
• Marine JC, Jochemsen AG. Mdmx and Mdm2: Brothers in arms?. Cell Cycle 2004; 3: 900–4
   PubMed Web of Science ®Google Scholar
• Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, et al. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2004; 2: 495–503
   PubMed Web of Science ®Google Scholar
• Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000; 60: 3650–4
   PubMed Web of Science ®Google Scholar
• Markus MA, Reichmuth C, Atkinson MJ, Reich U, Hoffmann I, Balling R, et al. Cadherin- 11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro. J Pathol 1999; 187: 164–72
   PubMed Web of Science ®Google Scholar
• Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999; 59: 947–52
   PubMed Web of Science ®Google Scholar